Frank Tufaro is Co-Chair of the Research and Development Committee of Replay. Frank was the CEO of DNAtrix, a clinical stage, biotechnology company developing oncolytic virus-driven immunotherapies for cancer. Previously Frank was the President and CEO of Allera Health Products and the Managing Director at Medigene Inc. He was one of the original founders of Neurovir, Inc. He served as Executive Director of PNP Therapeutics and as CEO and Chairman of Nurel Therapeutics.
Frank was a Professor in the Department of Microbiology, Department of Ophthalmology at the University of British Colombia in Canada and received his BSc in Biology and a PhD in Molecular Biology at McGill University. He completed his Postdoctoral Fellow with Dr. Steve L. McKnight at the Carnegie Institution of Washington and the Fred Hutchinson Cancer Center in Seattle.